Skip navigation

Multiplex Bioanalytics

Using sophisticated laboratory automation and proprietary targeted liquid chromatography-mass spectrometry (LC-MS) techniques, Ore Pharmaceuticals can elucidate novel pharmacological actions of drugs via the measurement of hundreds of disease-relevant biomolecules in biofluids collected from compound-treated animals. By observing changes in the levels of specific bioanalytes in biological fluids, affected biochemical pathways and processes can point to a wide range of organ systems that may be involved in potential disease pathologies. 

We can also identify activity induced by the compound and reveal potential alternative disease indications. Experts in key therapeutic areas have worked with us to select bioanalytics whose abundance carries specific disease relevance.  When combined with data from our other platform technologies, this information can enable the discovery of novel drug activities and bring to light new potential applications for further investigation.
';